Thermo Fisher Scientific TMO Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $1.66B-15.9% | $1.97B+21.5% | $1.62B+0.2% | $1.62B+7.1% | $1.51B-17.2% | ||
| $83M-1.2% | $84M+20.0% | $70M-13.6% | $81M+8.0% | $75M-5.1% | ||
| -$258M— | —— | -$127M+60.6% | -$322M-15.4% | -$279M-38.1% | ||
| $1.19B-65.5% | $3.46B+54.4% | $2.24B+60.0% | $1.4B+93.5% | $723M-78.0% | ||
| $376M-19.1% | $465M+15.1% | $404M+37.4% | $294M-18.8% | $362M-24.6% | ||
| $8.87B— | —— | —— | —— | $0— | ||
| $14M-56.3% | $32M-20.0% | $40M-14.9% | $47M-82.2% | $264M-80.2% | ||
| -$8.96B— | —— | -$4.12B-1,332% | -$288M+45.4% | -$527M— | ||
| $162M0.0% | $162M-0.6% | $163M+0.6% | $162M+8.7% | $149M0.0% | ||
| $3B+8,008% | $37M-96.2% | $963M— | $0-100% | $2B+100% | ||
| $5.24B+6.5% | $4.92B— | —— | —— | $2.84B— | ||
| $1.41B+79.4% | $787M— | $0-100% | $787M-6.1% | $838M-66.5% | ||
| $1.09B-69.0% | $3.53B+658% | -$632M+36.2% | -$991M-872% | -$102M+97.2% | ||
| $78M— | —— | —— | $311M+741% | $37M+114% | ||
| -$6.6B-184% | $7.87B+404% | -$2.59B-701% | $431M+227% | $132M+121% | ||
| $430M-1.4% | $436M+0.2% | $435M+1.2% | $430M+0.2% | $429M-2.1% | ||
| $1.11B— | —— | $104M-85.7% | $726M-49.1% | $1.43B— | ||
| -$88M+37.1% | -$140M-19.7% | -$117M-85.7% | -$63M+53.3% | -$135M+46.9% | ||
| —— | $93.75M0.0% | $93.75M0.0% | $93.75M0.0% | $93.75M+131% | ||
| $55M+5,600% | -$1M+92.9% | -$14M-100% | -$7M-800% | $1M+133% | ||
| $250M-80.9% | $1.31B— | —— | —— | $2M-99.9% | ||
| $9M-66.7% | $27M+575% | $4M+300% | $1M-91.7% | $12M-29.4% | ||
| $96M+92.0% | $50M-40.5% | $84M+78.7% | $47M-46.0% | $87M+77.6% | ||
| $389M— | —— | —— | —— | $0— | ||
| $39M-57.1% | $91M+2,375% | -$4M— | —— | $45M— | ||
| $816M-72.7% | $2.99B+63.1% | $1.84B+66.1% | $1.11B+206% | $361M-87.2% | ||
| $816M-72.7% | $2.99B+63.1% | $1.84B+66.1% | $1.11B+206% | $361M-87.2% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Thermo Fisher Scientific generate?
- Thermo Fisher Scientific (TMO) generated $8.3B in operating cash flow over the trailing twelve months.
- What is Thermo Fisher Scientific's free cash flow?
- After $1.5B of capital expenditures, Thermo Fisher Scientific's free cash flow was $6.7B over the trailing twelve months, up 0.4% year over year.
- Where does Thermo Fisher Scientific's cash flow data come from?
- Every line is extracted from Thermo Fisher Scientific's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
